These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31568656)

  • 21. Dengue Virus M Protein Promotes NLRP3 Inflammasome Activation To Induce Vascular Leakage in Mice.
    Pan P; Zhang Q; Liu W; Wang W; Lao Z; Zhang W; Shen M; Wan P; Xiao F; Liu F; Zhang W; Tan Q; Liu X; Wu K; Liu Y; Li G; Wu J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential humoral and cellular immunity induced by vaccination using plasmid DNA and protein recombinant expressing the NS3 protein of dengue virus type 3.
    Hurtado-Melgoza ML; Ramos-Ligonio A; Álvarez-Rodríguez LM; Meza-Menchaca T; López-Monteon A
    J Biomed Sci; 2016 Dec; 23(1):85. PubMed ID: 27903271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication.
    Teramoto T; Balasubramanian A; Choi KH; Padmanabhan R
    J Biol Chem; 2017 Jun; 292(23):9465-9479. PubMed ID: 28396347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of virus specific immune responses by IL-10 in acute dengue infection.
    Malavige GN; Jeewandara C; Alles KM; Salimi M; Gomes L; Kamaladasa A; Jayaratne SD; Ogg GS
    PLoS Negl Trop Dis; 2013; 7(9):e2409. PubMed ID: 24040431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of dengue virus-infected peripheral blood mononuclear cell death that correlates with the severity of illness.
    Jaiyen Y; Masrinoul P; Kalayanarooj S; Pulmanausahakul R; Ubol S
    Microbiol Immunol; 2009 Aug; 53(8):442-50. PubMed ID: 19659928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.
    Piazza P; Campbell D; Marques E; Hildebrand WH; Buchli R; Mailliard R; Rinaldo CR
    Clin Exp Immunol; 2014 Sep; 177(3):696-702. PubMed ID: 24816171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation in liver enzymes is associated with increased IL-2 and predicts severe outcomes in clinically apparent dengue virus infection.
    Senaratne T; Carr J; Noordeen F
    Cytokine; 2016 Jul; 83():182-188. PubMed ID: 27155816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF.
    Duangchinda T; Dejnirattisai W; Vasanawathana S; Limpitikul W; Tangthawornchaikul N; Malasit P; Mongkolsapaya J; Screaton G
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16922-7. PubMed ID: 20837518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies against dengue NS2B and NS3 proteins for the study of protein interactions in the flaviviral replication complex.
    Moreland NJ; Tay MY; Lim E; Rathore AP; Lim AP; Hanson BJ; Vasudevan SG
    J Virol Methods; 2012 Jan; 179(1):97-103. PubMed ID: 22040846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T-cells in acute dengue viral infection.
    Jayaratne HE; Wijeratne D; Fernando S; Kamaladasa A; Gomes L; Wijewickrama A; Ogg GS; Malavige GN
    Immunology; 2018 May; 154(1):89-97. PubMed ID: 29140541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection.
    Chagan-Yasutan H; Ndhlovu LC; Lacuesta TL; Kubo T; Leano PS; Niki T; Oguma S; Morita K; Chew GM; Barbour JD; Telan EF; Hirashima M; Hattori T; Dimaano EM
    J Clin Virol; 2013 Dec; 58(4):635-40. PubMed ID: 24239423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary dengue virus infections induce differential cytokine production in Mexican patients.
    Cruz Hernández SI; Puerta-Guardo HN; Flores Aguilar H; González Mateos S; López Martinez I; Ortiz-Navarrete V; Ludert JE; Angel RM
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):161-7. PubMed ID: 27008374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
    Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
    J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of interferon alpha in the sera of children with dengue virus infection.
    Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Ennis FA
    Am J Trop Med Hyg; 1993 Feb; 48(2):222-9. PubMed ID: 8447527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody and memory B cell responses to the dengue virus NS1 antigen in individuals with varying severity of past infection.
    Ramu ST; Dissanayake M; Jeewandara C; Bary F; Harvie M; Gomes L; Wijesinghe A; Ariyaratne D; Ogg GS; Malavige GN
    Immunology; 2023 Sep; 170(1):47-59. PubMed ID: 37075785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage.
    Fadilah SA; Sahrir S; Raymond AA; Cheong SK; Aziz JA; Sivagengei K
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):710-7. PubMed ID: 10928365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of IFN-Y +874 T/A polymorphism on clinical manifestations of dengue: a meta-analysis.
    Kaur G; Gupta K; Singh A; Kumar N; Banerjee I
    J Genet; 2021; 100():. PubMed ID: 34984984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection.
    Badolato-Corrêa J; Sánchez-Arcila JC; Alves de Souza TM; Santos Barbosa L; Conrado Guerra Nunes P; da Rocha Queiroz Lima M; Gandini M; Bispo de Filippis AM; Venâncio da Cunha R; Leal de Azeredo E; de-Oliveira-Pinto LM
    Immun Inflamm Dis; 2018 Jun; 6(2):194-206. PubMed ID: 29282904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
    Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
    Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease.
    Tian Y; Seumois G; De-Oliveira-Pinto LM; Mateus J; Herrera-de la Mata S; Kim C; Hinz D; Goonawardhana NDS; de Silva AD; Premawansa S; Premawansa G; Wijewickrama A; Balmaseda A; Grifoni A; Vijayanand P; Harris E; Peters B; Sette A; Weiskopf D
    Cell Rep; 2019 Dec; 29(13):4482-4495.e4. PubMed ID: 31875555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.